Posted on 6/24/16
National Pharmaceutical Council Welcomes Mallinckrodt as Its Newest Member
The National Pharmaceutical Council (NPC) today announced that Mallinckrodt Pharmaceuticals has joined the health policy research organization as its newest member. Steven Romano, MD, senior vice . . .
Posted on 6/24/16
PharmAthene to Join Russell 3000 and Global Indexes
PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that it is set to join the broad-market Russell 3000® Index . . .
Posted on 6/23/16
Why Emergent BioSolutions Inc. Procured a Lower Price Today
IMAGE SOURCE: GETTY IMAGES.What: Emergent BioSolutions (NYSE:EBS) is down 19% at 2:40 p.m. EDT after announcing that the U.S. Department of Health and Human Services (HHS) . . .
Posted on 6/22/16
New Health Sciences Completes NIH Contract to Develop Hemanext
New Health Sciences, Inc. (NHSi), a medical technology company focused on innovations to improve transfusion therapy, announced the successful completion of a National Institute of Health . . .
Posted on 6/22/16
Exostar's Life Sciences User Community Surges
Nearly 1,500 Industry Organizations Are Enhancing Security and Productivity with Exostar’s Identity and Access Management PlatformExostar, whose cloud-based solutions help companies in aerospace and defense, life . . .
Posted on 6/21/16
Klatt Family Joins MWPH to Advocate for Children’s Health
12th annual “Speak Now for Kids Family Advocacy Day” held in D.C.More than forty families and hospitals across the United States are in the nation’s capital . . .
Posted on 6/20/16
The Washington Post Names Privia Health a Winner of the Greater Washington 2016 Top Workplaces Award
WASHINGTON--(BUSINESS WIRE)--Privia Health, LLC, a national physician practice management and population health technology company, has been awarded a 2016 Top Workplaces honor by The Washington Post. . . .
Posted on 6/19/16
GlycoMimetics Prices Stock Offering
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC), a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, today announced the pricing of . . .
Posted on 6/17/16
Novavax Recognized by Washington Post as Top Workplace
GAITHERSBURG, Md., June 17, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), today announced that, for the third consecutive year, it has been recognized as a Top . . .
Posted on 6/20/16
Social & Scientific Systems Appoints Dr. Paul Gorrell as Group VP
Social & Scientific Systems, Inc. (SSS), a public health research company, is pleased to announce the appointment of Paul Gorrell, PhD
Posted on 6/17/16
Better Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc.
DNA. IMAGE SOURCE: GETTY IMAGES.Using DNA-based technology to battle Zika virus? That's what two companies are doing -- but in very different ways. Intrexon's (NYSE:XON) approach . . .
Posted on 6/17/16
Visa Joins the Alliance for Safe Online Pharmacies
WASHINGTON--(BUSINESS WIRE)--Visa Inc. (NYSE:V) is now a member of the Alliance for Safe Online Pharmacies(ASOP Global), it was announced today by ASOP Global’s Executive Director, Libby . . .
Posted on 6/17/16
GlycoMimetics Proposes Stock Offering
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC), a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, today announced that it intends . . .
Posted on 6/17/16
NORD Appoints Marshall L. Summar, MD, as Chairman of the Board
The National Organization for Rare Disorders (NORD), the leading, independent advocacy organization committed
Posted on 6/15/16
Take Shape For Life Named To 2016 Direct Selling Association Top 20
Medifast, Inc., a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today announced that its direct selling division, . . .
Posted on 6/15/16
Brand New Children’s National Health System Southeast Primary Care Facility to Begin Seeing Patients This Month
Children’s National Health System opened its doors to patients and families at the new Fort Davis location in Southeast Washington, DC.The Children’s Pediatricians & Associates Naylor . . .
Posted on 6/24/16
A Video Conversation with Greg Rochlin, CEO of Chesapeake Health Sciences, LLC
Brought to you by Nevins & Associates
Posted on 6/8/16
Children’s National Health System Only Washington, DC, Hospital Named to Becker’s Hospital Review 100 Great Hospitals in America
Children’s National Health System was named to the 2016 Becker’s Hospital Review list of 100 Great Hospitals in America.The list featured hospitals that are well known for quality, . . .
Posted on 6/22/16
A Video Conversation with Shannon Hexter, MS, MBA, CHS, Co-founder and Director for Patient Care Services at CHS, LLC
Brought to you by Nevins & Associates
Posted on 6/17/16
A Video Conversation with Allen Tien, MD, MHS, Co-founder and CMO of Chesapeake Health Sciences, LLC
Brought to you by Nevins & Associates
Posted on 6/8/16
Novavax To Expand Operations In Montgomery County, Plans To Add Up To 850 New Jobs
Growing company developing promising vaccines for RSV, influenza and EbolaNovavax, a clinical stage vaccine company that works to deliver novel products to prevent a broad range . . .
Posted on 6/8/16
3 Biotech Stocks Billionaires Are Buying That I'm Buying, Too
IMAGE SOURCE: FLICKR USER STOCKMONKEYS.COM.Billionaire investors have proven that they can profit in good and bad times, and while no one should blindly follow in the . . .
Posted on 6/7/16
CVS Pharmacy Now Open in Target Stores Throughout Washington
CVS Health (NYSE: CVS) today announced that the first CVS Pharmacy locations in Target stores are now open in Washington. The pharmacies, located in several metropolitan . . .
Posted on 6/7/16
Orgenesis and CureCell Awarded Grant From the KORIL Fund for Diabetes Research and Development
Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a fully integrated cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to . . .
Posted on 6/7/16
3 Reasons Behind Novavax, Inc.'s Superior Performance in May
What: Shares of Novavax (NASDAQ:NVAX), a clinical-stage vaccine development company focusing on an array of respiratory and infectious diseases, surged 16% in May, according to data . . .
Washington DC
